Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients.
about
Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed.HIV-associated anaerobes ferment TB risk.New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.The Microbiome and Tuberculosis: Early Evidence for Cross TalkThe Lung Microbiome and Its Role in Pneumonia
P2860
Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Anaerobic Bacterial Fermentati ...... ral-Drug-Treated HIV Patients.
@en
type
label
Anaerobic Bacterial Fermentati ...... ral-Drug-Treated HIV Patients.
@en
prefLabel
Anaerobic Bacterial Fermentati ...... ral-Drug-Treated HIV Patients.
@en
P2093
P2860
P50
P1433
P1476
Anaerobic Bacterial Fermentati ...... iral-Drug-Treated HIV Patients
@en
P2093
Alison Morris
Chunhai Ruan
Gregory Calligaro
Jose C Clemente
Keertan Dheda
Mauricio Danckers
Michael D Weiden
Philip Diaz
Rodney Dawson
P2860
P304
530-537.e4
P356
10.1016/J.CHOM.2017.03.003
P577
2017-03-30T00:00:00Z